Renin-angiotensin-aldosterone System Genomics In Essential Hypertension | 60078
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

2nd International Conference on Biotechnology and Healthcare

Auckland, New Zealand
Google scholar citation report
Citations : 1514

Journal of Biotechnology & Biomaterials received 1514 citations as per google scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Renin-angiotensin-aldosterone system genomics in essential hypertension

13th Biotechnology Congress

Kamna Srivastava

University of Delhi, India

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.067

Objectives: Hypertension is one of the major cardiovascular diseases. Candidate genes encoding the Renin-angiotensin-aldosterone system (RAAS), i.e., Angiotensin Converting Enzyme (ACE), Angiotensinogen, Angiotensin II Type-I receptor, Atrial natriuretic peptide (ANP) and Aldosterone synthase (CYP11B2), their expression at genetic and protein levels and their association with essential hypertension, if any, were investigated in a Northern Indian population. Methods: Genotyping and gene expression at mRNA and protein levels was carried out by PCR-RFLP, Real time PCR and Western blot respectively. Results: A significant association was found in the AT1R genotypes (AC+CC) with essential hypertension. The expression of angiotensinogen was also up-regulated in patients as compared to controls. The decreased levels of ANP gene expression at mRNA (85%) and protein (72.6%) levels and increased in CYP11B2 protein expression (1.53 fold) in the patient group as compared to controls were found. The individuals with rare allele in Angiotensinogen gene were found to have significant control in blood pressure with ACE inhibitor, Enalapril. Conclusion: Our findings suggest the association of candidate gene of RAAS with essential hypertension. The increased expression of Angiotensinogen converting enzyme, Angiotensinogen, Angiotensin II Type-I receptor gene and decreased levels of ANP gene expression at mRNA and protein levels in the patient group as compared to controls were significantly associated with essential hypertension and could be served as a prognostic biomarker for essential hypertension.

Kamna Srivastava has completed her BPharm, MPharm and PhD from Department of Pharmacology, Institute of Technology, Banaras Hindu University, India. She has held her Post-Doctoral positions in National Institute of Immunology and All India Institute of Medical Sciences, India. Presently, she is an Assistant Professor working in Molecular Cardiology Lab in Dr. B R Ambedkar Centre for Biomedical Research, University of Delhi, India. Her on-going project is focused on identifying the potential biomarkers for cardiovascular diseases. She has more than 30 research publications to her credit and is the recipient of grants from DST, CSIR and ICMR India.

Email: [email protected]